We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Tissue Genesis Signs Exclusive Distribution and License Agreement with Vet-Stem
News

Tissue Genesis Signs Exclusive Distribution and License Agreement with Vet-Stem

Tissue Genesis Signs Exclusive Distribution and License Agreement with Vet-Stem
News

Tissue Genesis Signs Exclusive Distribution and License Agreement with Vet-Stem

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Tissue Genesis Signs Exclusive Distribution and License Agreement with Vet-Stem"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Tissue Genesis, Inc. has announced an exclusive distribution and licensing agreement for the veterinary market with Vet-Stem, Inc. (Poway, California).

Tissue Genesis received a combination of equity and royalties under the agreement, and expects in the future to receive revenue from the sales to Vet-Stem of TGI 1000™ cell isolation systems, TGI 1000 disposables and TGI 100™ kits.

"This strategic alliance leverages Tissue Genesis' cell isolation expertise and opens up a new market for its TGI 1000 platform. It is truly a win-win for both companies, and more so for animal owners," said Anton C. Krucky, President and CEO of Tissue Genesis.

"Our agreement empowers Vet-Stem to take their veterinary solutions to a new level, and we are looking forward to working closely with their team as we continue to make strides to find innovative veterinary applications, such as cell-based emergency medicine,” said Krucky.

"Vet-Stem is the world leader in veterinary cell-based therapy and has treated over 3,000 horses and dogs with orthopedic injuries. This automation of our current successful methods will enable us to expand our markets globally," said Dr. Robert Harman, President and CEO of Vet-Stem.

Tissue Genesis expects its cell isolation system to process a small quantity of a patient's own fat tissue to produce large quantities of cells, including adult stem cells and microvascular cells.

Advertisement